7 days of Tobacco Cessation
Participants will be randomly assigned to 7 days of tobacco cessation.
Early onsetLoading study record…
Cannabis smokers who also smoke tobacco cigarettes have markedly higher rates of cannabis relapse relative to those who do not use tobacco. There is a clear need to develop and evaluate interventions for dual tobacco and cannabis users. The investigators of this study have previously shown that the co-use of tobacco cigarettes contributes to the maintenance of daily cannabis use, and that age of cigarette onset is a critical predictor of treatment outcome. Short-term tobacco cessation may suffice in altering cannabis relapse rates in later-onset cigarette smokers, while a longer period of tobacco cessation may be needed for earlier-onset smokers. In the current study, a human laboratory model will be utilized to determine whether cannabis relapse varies as a function of tobacco cessation duration and age of tobacco use onset.
Locally preserved from ClinicalTrials.govOpen ClinicalTrials.govlast source update 2026-09-01
What this record can show
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
Linked local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Interventions
Participants will be randomly assigned to 7 days of tobacco cessation.
Early onsetParticipants will be randomly assigned to 21 days of tobacco cessation.
Late onsetParticipants will receive cannabis.
Eligibility
primary outcomes
Time frame: During 9-day inpatient phase
Number of cannabis cigarettes participant chooses to smoke.
Publications
No exact PMID-linked public article is currently readable locally.